1. Microvessels in Epithelial Ovarian Tumors: High Microvessel Density Is a Significant Feature of Malignant Ovarian Tumors.
- Author
-
Sopo M, Anttila M, Muukkonen OT, YlÄ-Herttuala S, Kosma VM, Keski-Nisula L, and Sallinen H
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Carcinoma, Ovarian Epithelial metabolism, Carcinoma, Ovarian Epithelial mortality, Female, Humans, Immunohistochemistry, Kaplan-Meier Estimate, Lymphatic Vessels pathology, Middle Aged, Neoplasm Grading, Ovarian Neoplasms metabolism, Ovarian Neoplasms mortality, Prognosis, Young Adult, Carcinoma, Ovarian Epithelial pathology, Microvascular Density, Neovascularization, Pathologic metabolism, Ovarian Neoplasms pathology
- Abstract
Background/aim: Examine features of blood and lymphatic vessels in ovarian tumors and their significance to prognosis of ovarian cancer., Patients and Methods: A total of 139 women with epithelial ovarian tumors were included: 86 malignant, 17 borderline and 36 benign. Density, percentage, mean size and number of blood microvessels in tumors were measured by immunohistochemistry with antibodies against CD34 and CD105. Lymphatic vessel density was assayed using the D2-40 antibody against podoplanin., Results: Angiogenesis was most profuse in malignant tumors. Small size of lymph vessels predicted 26% shorter 5-year survival of ovarian cancer patients. Further, high percentage of lymphatic vessels in tumors was associated with lymph node metastasis, and high density with cancer recurrence. Lower number of microvessels, as assessed by CD34 staining, predicted shorter progression-free survival. Additionally, the large size of microvessels assessed by CD34 and the high number of vessels assessed by CD105 were related to residual tumor >1 cm at primary surgery and also, large vessel size was associated with stage III, as assessed by CD105 staining., Conclusion: CD34 and CD105 define different characteristics of microvessels. Parameters of lymph vessels may predict the prognosis of ovarian cancer., (Copyright © 2020 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF